| Literature DB >> 31065241 |
Xinyang Zhang1,2,3, Bohan Cheng1,2,3, Chang Liu1,2,3, Zhiqiang Du1,2,3, Hui Zhang1,2,3, Ning Wang1,2,3, Mengqi Wu1,2,3, Yumao Li1,2,3, Zhiping Cao1,2,3, Hui Li1,2,3.
Abstract
The transcription factor TCF21 has been previously shown to be specifically expressed in white preadipocytes in mice. However, the exact biological function of TCF21 in the context of adipogenesis remains unknown. In the current study, we used chicken lines selected based on their abdominal fat content, and observed a significant decrease in TCF21 mRNA and protein levels in the abdominal fat of lean broilers relative to fat broilers. Moreover, TCF21 expression increased throughout preadipocyte differentiation in vitro. We also found that TCF21 knockdown and over-expression attenuated and promoted preadipocyte differentiation, respectively, as evidenced by appropriate changes in lipid droplet accumulation and altered expressions of C/EBPa, LPL, and A-FABP. Additional chromatin immunoprecipitation analyses and luciferase assays demonstrated that TCF21 promotes the transcription of LPL by directly binding to the E-box motif in the LPL promoter. Together, these results show that TCF21 is a novel regulator of preadipocyte differentiation, in part by directly promoting LPL expression.Entities:
Keywords: LPL; TCF21; chicken; differentiation; preadipocyte
Year: 2019 PMID: 31065241 PMCID: PMC6489524 DOI: 10.3389/fphys.2019.00458
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
qPCR primer sequences.
| Gene | Accession number | Primer sequence (5′ to 3′) |
|---|---|---|
| NM_001277711 | F: ACGCTGCCAACGCAAGGG | |
| R: TGTTCACCACTTCTTTCAGGTCACTC | ||
| NM_001001460 | F: GTGCAATCAAAATGGAGCC | |
| R: CTTACAACCTTCACATGCAT | ||
| NM_001031459 | F: GCGACATCTGCGAGAACG | |
| R: GTACAGCGGGTCGAGCTT | ||
| NM_204290 | F: ATGTGCGACCAGTTTGT | |
| R: TCACCATTGATGCTGATAG | ||
| NM_205282 | F: ATGTTCATTGATTGGATGGAGGAG | |
| R: AAAGGTGGGACCAGCAGGAT | ||
| NM_001127439 | F: GGGGTGACTGGCGGTTGTA | |
| R: GCCGTAGAGGTTGGCGTAG | ||
| NM_001318990 | F: GACACCGGCTACTTCTCAGC | |
| R: CTCGCACATACTCGTCTCCA | ||
| NM_204126 | F: GGTCCGGGCCATGTTGA | |
| R: CAGGTTGGTGCGGGTGA | ||
| NM_205155 | F: AAGGCGGAAGTCAACGG | |
| R: TTGATGGTGAGGAGTCG | ||
| NM_205103 | F: GCGTTTTGCTGCTGTTATTATGAG | |
| R: TCCTTGCTGCCAGTCTGGAC | ||
| NC_006089 | F: ATGGAACAGGTGCTTCAACTCTCTC | |
| R: TTCACTTCTTTGGAGGGGAAATGAG | ||
| NC_006127 | F: CCCTTAAATAACTGATCCTTCACCC | |
| R: CGTACTGTGGAGAGACAGAGTTGCC |
Figure 1TCF21 expression in the abdominal fat tissues of lean and fat line chickens. (A) Relative TCF21 mRNA levels in the abdominal fat of lean and fat broilers as measured by real-time quantitative PCR (N = 5 per line). (B) TCF21 protein levels in the abdominal fat of lean and fat broilers aged 1–7 weeks as measured by western blot (N = 4 per line). (C) Western blot data quantification (N = 4 per line). Data are means ± SD; ∗P < 0.05, ∗∗P < 0.01.
Figure 2TCF21 expression during preadipocyte differentiation. (A) TCF21 expression in chicken preadipocytes (SV) and mature adipocytes (FC) as measured by qPCR (means ± SD; ∗∗P < 0.01). (B) Western blots analysis of TCF21 protein levels in chicken preadipocytes (SV) and mature adipocytes (FC). (C) TCF21 mRNA expression pattern over the course of preadipocyte differentiation as measured by qPCR (means ± SD). Different uppercase letters above columns denote significant differences between time points. (D) Western blots analysis of TCF21 protein levels during preadipocyte differentiation. Experiments above were conducted thrice and in triplicates.
Figure 3TCF21 knock-down attenuates chicken preadipocyte differentiation. (A) TCF21 mRNA knock-down efficiency in chicken preadipocytes as measured by qPCR after transfection with si-NC or si-TCF21 for 24, 48, and 72 h, respectively (means ± SD). (B) Oil red O staining of chicken preadipocytes transfected with si-NC or si-TCF21 (means ± SD). (C) Expression of adipogenic genes in chicken preadipocytes measured by qPCR after transfection with si-NC or si-TCF21 (means ± SD). ∗P < 0.05, ∗∗P < 0.01. Experiments above were conducted thrice and in triplicates. PPARγ, peroxisome proliferator-activated receptor gamma; C/EBPα, CCAAT/enhancer binding protein alpha; A-FABP, adipocyte fatty acid binding protein; LPL, lipoprotein lipase; PLIN, perilipin protein; KLF7, kruppel like factor 7; SREBP1, sterol regulatory element binding transcription factor 1; FAS, fatty acid synthase.
Figure 4TCF21 over-expression promotes chicken preadipocyte differentiation. (A) TCF21 protein over-expression efficiency in chicken preadipocytes as measured by western blot after transfection using pCMV-HA or pCMV-HA-TCF21. Lanes 1, 3, 5 and lanes 2, 4, 6 were chicken preadipocytes transfected with pCMV-HA-TCF21 and pCMV-HA, respectively, for 48, 72, and 96 h. (B) Oil red O staining of preadipocytes transfected using pCMV-HA or pCMV-HA-TCF21 (means ± SD). (C) Expression analysis of adipogenic genes in chicken preadipocytes measured by qPCR after transfection with pCMV-HA or pCMV-HA-TCF21, respectively (means ± SD). ∗P < 0.05, ∗∗P < 0.01. Experiments above were conducted thrice and in triplicates. PPARγ, peroxisome proliferator-activated receptor gamma; C/EBPα, CCAAT/enhancer binding protein alpha; A-FABP, adipocyte fatty acid binding protein; LPL, lipoprotein lipase; PLIN, perilipin protein; KLF7, kruppel like factor 7; SREBP1, sterol regulatory element binding transcription factor 1; FAS, fatty acid synthase.
Figure 5LPL is a target of TCF21. (A) Schematic diagram of the chicken A-FABP and LPL promoter sequences, with arrows indicating the forward and reverse primers used to amplify ChIP products. (B) Verification of chromatin immunoprecipitation by qPCR. Three independent immunoprecipitation reactions were analyzed, and the fold enrichment is provided in red at the bottom of the image. (C) Schematic representation of the A-FABP and LPL promoter constructs used in luciferase-based experiments, with letters indicating TCF21 binding site mutations. (D) Luciferase activity assay in DF-1 cells after co-transfection of pGL3-basic-A-FABP or pGL3-basic-LPL with either wild-type or mutated TCF21 binding site (bs) and the pCMV-HA or pCMV-HA-TCF21 vector (means ± SD). ∗∗P < 0.01. (E) Luciferase activity assay in ICP2 after co-transfection of pGL3-basic-A-FABP or pGL3-basic-LPL with either wild-type or mutated TCF21 binding site (bs) and the pCMV-HA or pCMV-HA-TCF21 vector (means ± SD). ∗P < 0.05, ∗∗P < 0.01. Experiments conducted thrice and in triplicates for results presented in (B,D,E). A-FABP, adipocyte fatty acid binding protein; LPL, lipoprotein lipase; TCF21, transcription factor 21.